妊娠期糖尿病患者孕中晚期糖脂代谢指标与妊娠结局的关联分析OA
Association Between Mid-to Late-Pregnancy Glycolipid Metabolic Indices and Pregnancy Outcomes in Patients with Gestational Diabetes Mellitus
目的 探讨妊娠期糖尿病(GDM)患者孕中晚期糖脂代谢指标的变化与妊娠结局的关系,分析糖脂代谢指标的动态变化对预测不良妊娠结局的价值.方法 选取 2024 年 1 月至 2024 年 12 月在濮阳市人民医院接受产检并分娩的77 例GDM孕妇,采集孕中期(孕 24~28 周)和孕晚期(孕 36~40 周)的糖脂代谢指标,包括空腹血糖(FPG)、胰岛素(INS)、C肽(CP)、糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C).按照孕妇的妊娠结局分为正常结局组(n=56)和不良结局组(n=21),对比两组GDM孕妇孕中晚期各指标的水平差异及其动态变化(Δ值)差异,并通过多因素Logistic回归分析筛选与不良妊娠结局相关的糖脂代谢指标,并使用ROC曲线分析其预测能力.结果 孕中期和孕晚期,不良结局组FPG、INS、CP、HbA1c、TC、TG、LDL-C水平均高于正常结局组,HDL-C水平低于正常结局组,差异有统计学意义(P<0.05).将两组GDM孕妇的孕晚期和孕中期糖脂代谢指标结果做差值,结果显示,随着孕期进展至孕晚期,不良结局组孕妇ΔFPG和ΔHbA1c水平均表现为上升,差异有统计学意义(P<0.05),而正常结局组则呈现下降趋势,差异有统计学意义(P<0.05);ΔINS、ΔCP、ΔTG的增幅显著大于正常结局组,差异有统计学意义(P<0.05).两组孕妇ΔTC、ΔLDL-C及ΔHDL-C的变化幅度比较,差异无统计学意义(P>0.05).多因素Logistic回归分析显示,TG的增长幅度、HbA1c的增长幅度和INS的增长幅度是GDM孕妇发生不良妊娠结局的独立危险因素(P<0.05).联合ΔTG、ΔHbA1c和ΔINS的模型相对于各指标单一应用具有更高的预测准确性,AUC值为 0.963;并且三个指标联合应用的预测模型灵敏度为 0.952,特异度为 0.893,均高于单一指标的灵敏度和特异度.结论 糖脂代谢指标的变化在妊娠期糖尿病患者的妊娠结局中具有重要预测价值,糖脂代谢动态变化趋势(尤其是ΔTG、ΔHbA1c和ΔINS)有助于更早、更准确地识别出现不良妊娠结局的高风险GDM孕妇,从而推动临床关于GDM孕妇的早期干预和个体化管理.
Objective To investigate the relationship between changes in glycolipid metabolic indices during mid-to late pregnancy and pregnancy outcomes in patients with gestational diabetes mellitus(GDM),and to evaluate the predictive value of dynamic changes in these indices for adverse pregnancy outcomes.Methods A total of 77 women with GDM who received antenatal care and delivered at Puyang People's Hospital from January 2024 to December 2024 were enrolled.Glycolipid metabolic indices were collected in mid-pregnancy(24~28 gestational weeks)and late pregnancy(36~40 gestational weeks),including fasting plasma glucose(FPG),insulin(INS),C-peptide(CP),glycated hemoglobin(HbA1c),total cholesterol(TC),triglycerides(TG),low-density lipoprotein cholesterol(LDL-C),and high-density lipoprotein cholesterol(HDL-C).According to pregnancy outcomes,the participants were assigned to a normal outcome group(n=56)and an adverse outcome group(n=21).Differences in the levels of these indices in mid-and late pregnancy,as well as differences in their dynamic changes(Δ values),were compared between groups.Multivariable logistic regression was performed to identify glycolipid metabolic indices associated with adverse pregnancy outcomes,and receiver operating characteristic(ROC)curve analysis was used to assess predictive performance.Results In both mid-pregnancy and late pregnancy,levels of FPG,INS,CP,HbA1c,TC,TG,and LDL-C were higher in the adverse outcome group than in the normal outcome group,whereas HDL-C was lower in the adverse outcome group;the differences were statistically significant(P<0.05).When the glycolipid metabolic indices in late pregnancy were subtracted from those in mid-pregnancy,the results showed that,with progression to late pregnancy,ΔFPG and ΔHbA1c increased in the adverse outcome group(P<0.05),whereas they showed a decreasing trend in the normal outcome group(P<0.05).In addition,the increases in ΔINS,ΔCP,and ΔTG were significantly greater in the adverse outcome group than in the normal outcome group(P<0.05).There were no statistically significant differences between groups in the magnitudes of change for ΔTC,ΔLDL-C,or ΔHDL-C(P>0.05).Multivariable logistic regression analysis indicated that the increase in TG,the increase in HbA1c,and the increase in INS were independent risk factors for adverse pregnancy outcomes in women with GDM(P<0.05).A combined model incorporating ΔTG,ΔHbA1c,and ΔINS showed higher predictive accuracy than any single index alone,with an area under the ROC curve(AUC)of 0.963.The combined model yielded a sensitivity of 0.952 and a specificity of 0.893,both higher than those of each single index.Conclusion Changes in glycolipid metabolic indices have important predictive value for pregnancy outcomes in patients with GDM.Dynamic trends in glycolipid metabolism—particularly ΔTG,ΔHbA1c,and ΔINS—may facilitate earlier and more accurate identification of high-risk women with GDM who are likely to develop adverse pregnancy outcomes,thereby promoting early intervention and individualized clinical management for women with GDM.
梁丽瑞;高湘玲;王敏
濮阳市人民医院 产科一病区,河南 濮阳 457000濮阳市人民医院 产科一病区,河南 濮阳 457000濮阳市人民医院 产科一病区,河南 濮阳 457000
医药卫生
妊娠期糖尿病糖脂代谢妊娠结局预测模型
gestational diabetes mellitusglycolipid metabolismpregnancy outcomepredictive model
《临床研究》 2026 (1)
13-17,5
评论